Browsing by Author 허우영

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 29 of 29

Issue DateTitleAuthor(s)
2014-11A Discovery Strategy for Selective Inhibitors of c-Src in Complex with the Focal Adhesion Kinase SH3/SH2-binding RegionJamie A. Moroco; Matthew P. Baumgartner; Heather L. Rust, et al
2013-10A novel small molecule inducer of cellular antioxidant response허우영
2010-05A Small-Molecule Inducer of the Antioxidant Response Element허우영; Zheng Sun; Tao Jiang, et al
2010-03A Structure-Guided Approach to Creating Covalent FGFR InhibitorsWenjun Zhou; 허우영; Ultan McDermott, et al
2006-02Allosteric inhibitors of Bcr-abl-dependent cell proliferationFrancisco J Adrian; Qiang Ding; Taebo Sim, et al
2015-10Antitumor Effects and Mechanisms of AZD4547 on FGFR2-Deregulated Endometrial Cancer Cells곽연의; 조한나; 허우영, et al
2013-04Characterization of Torin2, an ATP-competitive inhibitor of mTOR, ATM, and ATRQingsong Liu; Chunxiao Xu; Sivapriya Kirubakaran, et al
2008-07Clinical stage EGFR inhibitors irreversibly alkylate Bmx kinase허우영; Anastasia Velentza; Sungjoon Kim, et al
2012-09Development of ATP-Competitive mTOR Inhibitors허우영; Qingsong Liu; Seong A. Kang, et al
2014-11Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitorsLi Tan; Jun Wang; Junko Tanizaki, et al
2011-05Discovery and optimization of potent and selective benzonaphthyridinone analogs as small molecule mTOR inhibitors with improved mouse microsome stabilityQingsong Liu; Jinhua Wang; Seong A. Kang, et al
2010-09Discovery of 1-(4-(4-Propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a Highly Potent, Selective Mammalian Target of Rapamycin (mTOR) Inhibitor for the Treatment of CancerQingsong Liu; Jae Won Chang; Jinhua Wang, et al
2011-02Discovery of 9-(6-Aminopyridin-3-yl)-1-(3-(trifluoromethyl)-phenyl)benzo[h][1,6]naphthyridin-2(1H)-one (Torin2) as a Potent, Selective, and Orally Available Mammalian Target of Rapamycin (mTOR) Inhibitor for Treatment of CancerQingsong Liu; Jinhua Wang; Seong A. Kang, et al
2013-04Discovery of a Selective Irreversible BMX Inhibitor for Prostate CancerFeiyang Liu; Xin Zhang; Ellen Weisberg, et al
2006-02Discovery of EGFR Selective 4,6-Disubstituted Pyrimidines from a Combinatorial Kinase-Directed Heterocycle LibraryQiong Zhang; Yi Liu; Feng Gao, et al
2016-10Identification and chracterization of novel small molecule suppressor and inducer of intracellular reactive oxygen species as a potential neuroprotective agent and a potential anticancer agent허우영
2015-05Identification of Novel ROS Inducers: Quinone Derivatives Tethered to Long Hydrocarbon Chains홍연선; Sandip Sengupta; 허우영, et al
2012-03Kinome-wide Selectivity Profiling of ATP-competitive Mammalian Target of Rapamycin (mTOR) Inhibitors and Characterization of Their Binding KineticsQingsong Liu; Sivapriya Kirubakaran; 허우영, et al
2013-12Nrf2 활성화를 통한 세포내 항산화 반응을 일으키는 화합물허우영
2014-12Patient-derived models of acquired resistance can identify effective drug combinations for cancerAdam S. Crystal; Alice T. Shaw; Lecia V. Sequist, et al
2012-04Selective ATP-Competitive Inhibitors of TOR Suppress Rapamycin-Insensitive Function of TORC2 in Saccharomyces cerevisiaeQingsong Liu; Tao Ren; Tara Fresques, et al
2011-02Small molecule modulators of antioxidant response pathway허우영; Nathanael S Gray
2012-04Small-Molecule Inhibitors of the c-Fes Protein-Tyrosine KinaseSabine Hellwig; Chandra V. Miduturu; Shigeru Kanda, et al
2004-02Synthesis and Target Identification of Hymenialdisine AnalogsYongqin Wan; 허우영; Charles Y. Cho, et al
2003-04Synthetic small molecules that control stem cell fateSheng Ding; Tom Y. H. Wu; Achim Brinker, et al
2012Systematic identification of genomic markers of drug sensitivity in cancer cellsMathew J. Garnett; Elena J. Edelman; Sonja J. Heidorn, et al
2012-04Using combination therapy to override stromal-mediated chemoresistance in mutant FLT3-positive AML: synergism between FLT3 inhibitors, dasatinib/multi-targeted inhibitors and JAK inhibitorsE Weisberg; Q Liu; Erik Nelson, et al
2015-07-07약물 부작용이 감소된 급성골수성백혈병 표적치료제심태보; 윤호종; 허우영
2015-06히스톤 탈아세틸화 효소와 저해제의 기전허우영